These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effects of chronically exogenous oxytocin on ovary and uterus: A comparison of intraperitoneal and intranasal administration. Senturk GE; Sezer Z; Sahin H; Isildar B; Abdulova A Peptides; 2023 Jul; 165():171006. PubMed ID: 37003476 [TBL] [Abstract][Full Text] [Related]
27. Chronic intranasal oxytocin reverses stress-induced social avoidance in female prairie voles. Hale LH; Tickerhoof MC; Smith AS Neuropharmacology; 2021 Oct; 198():108770. PubMed ID: 34461067 [TBL] [Abstract][Full Text] [Related]
28. Null results of oxytocin and vasopressin administration across a range of social cognitive and behavioral paradigms: Evidence from a randomized controlled trial. Tabak BA; Teed AR; Castle E; Dutcher JM; Meyer ML; Bryan R; Irwin MR; Lieberman MD; Eisenberger NI Psychoneuroendocrinology; 2019 Sep; 107():124-132. PubMed ID: 31128568 [TBL] [Abstract][Full Text] [Related]
29. Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery. Song Z; Albers HE Front Neuroendocrinol; 2018 Oct; 51():14-24. PubMed ID: 29054552 [TBL] [Abstract][Full Text] [Related]
30. Is there a Publication Bias in Behavioural Intranasal Oxytocin Research on Humans? Opening the File Drawer of One Laboratory. Lane A; Luminet O; Nave G; Mikolajczak M J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26991328 [TBL] [Abstract][Full Text] [Related]
31. Modulating social behavior with oxytocin: how does it work? What does it mean? Churchland PS; Winkielman P Horm Behav; 2012 Mar; 61(3):392-9. PubMed ID: 22197271 [TBL] [Abstract][Full Text] [Related]
32. Acute effects of intranasal oxytocin on subjective and behavioral responses to social rejection. Alvares GA; Hickie IB; Guastella AJ Exp Clin Psychopharmacol; 2010 Aug; 18(4):316-21. PubMed ID: 20695687 [TBL] [Abstract][Full Text] [Related]
33. Antiaggressive activity of central oxytocin in male rats. Calcagnoli F; de Boer SF; Althaus M; den Boer JA; Koolhaas JM Psychopharmacology (Berl); 2013 Oct; 229(4):639-51. PubMed ID: 23624810 [TBL] [Abstract][Full Text] [Related]
34. How Can Intranasal Oxytocin Research Be Trusted? A Systematic Review of the Interactive Effects of Intranasal Oxytocin on Psychosocial Outcomes. Mierop A; Mikolajczak M; Stahl C; Béna J; Luminet O; Lane A; Corneille O Perspect Psychol Sci; 2020 Sep; 15(5):1228-1242. PubMed ID: 32633663 [TBL] [Abstract][Full Text] [Related]
35. Long-term exposure to intranasal oxytocin in a mouse autism model. Bales KL; Solomon M; Jacob S; Crawley JN; Silverman JL; Larke RH; Sahagun E; Puhger KR; Pride MC; Mendoza SP Transl Psychiatry; 2014 Nov; 4(11):e480. PubMed ID: 25386957 [TBL] [Abstract][Full Text] [Related]
36. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial. Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875 [TBL] [Abstract][Full Text] [Related]